立方制药: 2025年第一次临时股东大会的法律意见书

Group 1 - The company held its first extraordinary general meeting of shareholders on August 29, 2025, at 14:30 in Hefei, Anhui Province [1][2] - The meeting was convened following the resolution of the company's fifth board of directors on August 12, 2025, and the notice was published on August 13, 2025 [2][3] - A total of 6 proposals were reviewed during the meeting, including amendments to the company's articles of association and the election of the sixth board of directors [3][4] Group 2 - 17 shareholder representatives attended the meeting in person, representing 18 shareholders, while 123 shareholders participated via online voting, accounting for 4.9058% of the total voting shares [3][4] - The meeting's convenor was the company's board of directors, which met the qualifications set by Chinese laws and the company's articles of association [5] Group 3 - The voting process included both on-site and online voting, with results announced at the meeting [6][7] - The first proposal regarding the amendment of the articles of association was passed with 99.9904% approval from the attending shareholders [6][10] - The election of non-independent directors and independent directors also received significant support, with approval rates around 98.1595% [7][9] Group 4 - The proposal for the three-year dividend return plan (2026-2028) was approved with 99.9638% of the votes [12][13] - The adjustment of independent director allowances was also passed with a similar majority [13]